Congress Approves Final Version of Compounding Legislation From AMA's November 27, 2013, Advocacy Update On Nov. 18, the Senate passed by voice vote H.R. 3204, the “Drug Quality and Security Act.” This legislation, which passed the House on Sept. 28, is expected to be signed by the president shortly. It establishes new FDA regulatory oversight for those who compound sterile drugs, while ensuring that traditional compounding practices continue. Additionally, it strengthens the prescription drug supply chain, protecting Americans against counterfeit drugs. The legislation is a critical step to ensure compounding practices are safe and is expected to ... December 10, 2013 Regulations Compounding Pharmacies 0 0 Comment Read More »
National Physician Payment Transparency Program FAQs The following are frequently asked questions (FAQs) regarding the National Physician Payment Transparency Program (Open Payments) — initiated by the Physicians Payments Transparency Act (PPSA): These FAQs are based on the guidance that is publicly available as of August 23, 2013. This is a new reporting program, and many of the questions are still being clarified. Medical societies may take different positions on some of these questions. Readers of this document are encouraged to consult their attorneys, funding organizations, and CMS for interpretations of the Physician Payment Sunshine Act (PPSA) and the regulations operationalizing it. The information ... November 20, 2013 Regulations Sunshine Law 0 0 Comment Read More »